Van Gilst WH - Search Results

1

Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation.

Brundel BJ, Van Gelder IC, Henning RH, Tieleman RG, Tuinenburg AE, Wietses M, Grandjean JG, Van Gilst WH, Crijns HJ. Brundel BJ, et al. Among authors: van gilst wh, van gelder ic. Circulation. 2001 Feb 6;103(5):684-90. doi: 10.1161/01.cir.103.5.684. Circulation. 2001. PMID: 11156880

2

Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.

Wiesfeld AC, Crijns HJ, Van Veldhuisen DJ, Van Gilst WH, Lie KI. Wiesfeld AC, et al. Among authors: van gilst wh, van veldhuisen dj. Clin Cardiol. 1992 Sep;15(9):689-92. doi: 10.1002/clc.4960150912. Clin Cardiol. 1992. PMID: 1395204 Free article.

3

Differences in vasomotor control between human gastroepiploic and left internal mammary artery.

Buikema H, Grandjean JG, van den Broek S, van Gilst WH, Lie KI, Wesseling H. Buikema H, et al. Among authors: van gilst wh, van den broek s. Circulation. 1992 Nov;86(5 Suppl):II205-9. Circulation. 1992. PMID: 1424001

4

The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines.

Van Veldhuisen DJ, Girbes AR, Crijns HJ, Smit AJ, Van Gilst WH, Lie KI. Van Veldhuisen DJ, et al. Among authors: van gilst wh. Int J Clin Pharmacol Res. 1991;11(3):159-65. Int J Clin Pharmacol Res. 1991. PMID: 1687321

5

Flecainide: long-term effects in patients with sustained ventricular tachycardia or ventricular fibrillation.

van Wijk LM, Crijns HJ, Kingma HJ, van Gilst WH, van Gelder IC, Wesseling H, Lie KI. van Wijk LM, et al. Among authors: van gilst wh, van gelder ic. J Cardiovasc Pharmacol. 1990 Jun;15(6):884-91. J Cardiovasc Pharmacol. 1990. PMID: 1694910

6

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.

Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KI. Crijns HJ, et al. Among authors: van gilst wh, van gelder ic. Am J Cardiol. 1991 Aug 1;68(4):335-41. doi: 10.1016/0002-9149(91)90828-9. Am J Cardiol. 1991. PMID: 1907089

7

Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter.

Van Gelder IC, Crijns HJ, Van der Laarse A, Van Gilst WH, Lie KI. Van Gelder IC, et al. Among authors: van gilst wh, van der laarse a. Am Heart J. 1991 Jan;121(1 Pt 1):51-6. doi: 10.1016/0002-8703(91)90954-g. Am Heart J. 1991. PMID: 1985377

8

Decrease of right and left atrial sizes after direct-current electrical cardioversion in chronic atrial fibrillation.

Van Gelder IC, Crijns HJ, Van Gilst WH, Hamer HP, Lie KI. Van Gelder IC, et al. Among authors: van gilst wh. Am J Cardiol. 1991 Jan 1;67(1):93-5. doi: 10.1016/0002-9149(91)90108-w. Am J Cardiol. 1991. PMID: 1986512 No abstract available.

9

Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.

Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Van Gelder IC, et al. Among authors: van gilst wh. Am J Cardiol. 1991 Jul 1;68(1):41-6. doi: 10.1016/0002-9149(91)90707-r. Am J Cardiol. 1991. PMID: 2058558

10

Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation.

van Wijk LM, den Heijer P, Crijns HJ, van Gilst WH, Lie KI. van Wijk LM, et al. Among authors: van gilst wh. J Cardiovasc Pharmacol. 1989 Jan;13(1):32-6. doi: 10.1097/00005344-198901000-00005. J Cardiovasc Pharmacol. 1989. PMID: 2468933 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters